NAV
Explore a selection of essential drug information below, or:
Unlock enhanced features & extensive drug insights. Create a free account.
Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.

Ambrosia trifida pollen

Explore a selection of our essential drug information below, or:

CREATE FREE ACCOUNT
Full Drug Profiles
Unlock enhanced features & extensive drug insights, including detailed interaction data & regulatory status. Create a free account.
SUBSCRIBERECOMMENDED FOR PHARMA
Data Packages
Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.

Identification

Summary

Ambrosia trifida pollen is an extract from Ambrosia trifida pollen used in allergy testing.

Generic Name
Ambrosia trifida pollen
DrugBank Accession Number
DB10386
Background

Ambrosia trifida pollen is the pollen of the Ambrosia trifida plant. Ambrosia trifida pollen is mainly used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • giant ragweed pollen extract
Get Early Access To DrugBank+
Be among the first to try our new AI-powered, game-changing platform. DrugBank+ is here to streamline your pharmaceutical research and deliver faster insights and smarter decisions.
Join the Waitlist
Get Early Access To DrugBank+
Join the Waitlist

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available
Unlock the secrets to drugging the undruggable
Discover how groundbreaking research is turning "undruggable" targets into therapeutic opportunities.
Download eBook
Unlock the secrets to drugging the undruggable
Download eBook

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Ambrosia Trifida PollenInjection, solution0.05 g/1mLSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Ambrosia Trifida PollenInjection, solution40000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1965-01-012021-11-30US flag
Ambrosia Trifida PollenInjection, solution0.10 g/1mLSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Ambrosia Trifida PollenInjection, solution1000 [PNU]/1mLIntradermalALK-Abello, Inc.1965-01-012023-05-22US flag
Ambrosia Trifida PollenInjection, solution20000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1965-01-012023-05-18US flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
3-ragweed Mix, Giant/short/western PollenAmbrosia trifida pollen (0.33 g/20mL) + Ambrosia artemisiifolia pollen (0.34 g/20mL) + Ambrosia psilostachya pollen (0.33 g/20mL)Injection, solutionPercutaneous; SubcutaneousAllergy Laboratories, Inc.1967-12-07Not applicableUS flag
Mixed RagweedAmbrosia trifida pollen (0.1 g/1mL) + Ambrosia artemisiifolia pollen (0.1 g/1mL)Injection, solutionPercutaneous; SubcutaneousALK-Abello, Inc.2015-05-03Not applicableUS flag
Mixed RagweedAmbrosia trifida pollen (20000 [PNU]/1mL) + Ambrosia artemisiifolia pollen (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixed RagweedAmbrosia trifida pollen (20000 [PNU]/1mL) + Ambrosia artemisiifolia pollen (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1975-01-15Not applicableUS flag
Mixed RagweedAmbrosia trifida pollen (10000 [PNU]/1mL) + Ambrosia artemisiifolia pollen (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-012023-05-19US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
KU1V1898XX
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910561
RxNav
851998

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
Unlock 175K+ rows when you subscribe.View sample data

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionPercutaneous; Subcutaneous
Injection, solutionIntradermal1000 [PNU]/1mL
Injection, solutionPercutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.10 g/1mL
Injection, solutionSubcutaneous20000 [PNU]/1mL
Injection, solutionSubcutaneous40000 [PNU]/1mL
Injection, suspensionSubcutaneous10000 [PNU]/1mL
Injection, suspensionSubcutaneous20000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.001 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.05 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.1 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous20000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous40000 [PNU]/1mL
InjectionCutaneous; Intradermal; Subcutaneous0.05 g/1mL
Injection, solutionPercutaneous; Subcutaneous1 g/20mL
Injection, solutionPercutaneous
Injection, solutionSubcutaneous
SolutionIntradermal; Percutaneous; Subcutaneous
Injection, solutionIntradermal500 [PNU]/1mL
Injection, solutionPercutaneous; Subcutaneous0.05 g/1mL
Injection, solutionPercutaneous; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal; Subcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous40000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53